Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Liver modified enzymes

Correct answer = B. The increased insulin and decreased glucagon levels characteristic of the fed state promote the synthesis of fructose 2,6-bisphosphate. Most covalently modified enzymes are in the dephosphorylated state and are active. Acetyl CoA is not elevated in the fed state. The transport of glucose in the liver is not insulin sensitive. Synthesis of glucokinase is enhanced in the fed state. [Pg.334]

It was originally assumed that in LADH the zinc existed in an octahedral form with six bonds available for coordination, until in 1967 Vallee and co-workers showed that the enzyme contained two different types of zinc atom.13773 Loss of two zinc atoms from the enzyme resulted in loss of catalytic activity but maintained the tertiary structure. It was postulated from this that one metal ion per subunit played a role maintaining the tertiary structure, while the other zinc functioned in a catalytic role. Only two of the zinc ions in the liver enzyme interact with the inhibitors 1,10-phenanthroline and 2,2 -bipyridyl, thus demonstrating the different chemical reactivities of the zinc ions.1378 It was also shown that one zinc per subunit could be selectively exchanged or removed by dialysis. This modified enzyme containing one zinc per subunit did not bind 1,10-phenanthroline, hence the catalytic zinc is removed first during dialysis.1379 The second zinc atom can be selectively removed in preference to the catalytic zinc, by carboxymethylation followed by dialysis.1377 ... [Pg.1012]

The activation of liver FDPase by a variety of sulfhydryl reagents has been examined by Little et al. (46), and their results generally confirm those reported by Pontremoli and his co-workers. In the disulfide exchange reaction 5,5 -dithio-bis(2-nitrobenzoic) acid was most effective (45), and in general, the disulfides were more effective than reagents such as p-mercuribenzoate or iodoacetamide. The nature of the group introduced appears to affect the conformation of the modified enzyme. [Pg.623]

In the different compartments metabolic processes can transform the drugs. In some cases reactions transform a compound into an active drug (prodrug-drug transformation). But in most cases metabolic enzymes in the liver modify compounds into inactive or toxic products that are further metabolised or excreted. Especially about twenty different cytochromes in the liver contribute to this biotransformation. Now chemoinformatic tools can partly predict the bioavailability of compounds as described in the text. [Pg.1785]

Similar problems have compUcated the quantitation of HMG-CoA reductase activity as a measure of the rate of cholesterol synthesis. For example, it has not been established as firmly for the intestine as for the hver that this enzyme is rate limiting to the overall synthesis of the cholesterol molecule [23]. Furthermore, HMG-CoA reductase in both the intestine and liver is subject to a phosphorylation-dephosphorylation reaction that modifies enzyme activity and is involved in the activation of an inactive (phosphorylated) to an active (dephos-phorylated) form during homogenization of the mucosa [24,25]. Finally, HMG-CoA reductase is incompletely recovered from the mucosa during preparation of micro-somes [26,27] and is very sensitive to inactivation by proteases present in the intestine [28]. These various technical problems have led to considerable confusion with respect to various aspects of intestinal cholesterol synthesis and have made it difficult to interpret quantitatively some of the results presented below. [Pg.126]

Sulphatases.—Desialylization of sulphatase A from ox liver with neuraminidase slightly modified the charge on the molecule, but did not alter any other properties. The modified enzyme was able to hydrolyse cerebroside sulphate. [Pg.482]

Figr.3 Distribution of some enzymes in submltochondrlal fractions of rat liver /modified from KoJ et al., 1975/. 0 - outer membrane S - Interraembrane space 1 - inner membrane M - matrix. [Pg.497]

PMeOZO-coupled bovine liver catalase was prepared and enabled the enzyme to be used in organic solvents (Scheme 59). The modified enzyme showed catalytic activity in water as well as in benzene and chloroform. [Pg.422]

In addition to the mechanistic simulation of absorptive and secretive saturable carrier-mediated transport, we have developed a model of saturable metabolism for the gut and liver that simulates nonlinear responses in drug bioavailability and pharmacokinetics [19]. Hepatic extraction is modeled using a modified venous equilibrium model that is applicable under transient and nonlinear conditions. For drugs undergoing gut metabolism by the same enzymes responsible for liver metabolism (e.g., CYPs 3A4 and 2D6), gut metabolism kinetic parameters are scaled from liver metabolism parameters by scaling Vmax by the ratios of the amounts of metabolizing enzymes in each of the intestinal enterocyte compart-... [Pg.436]

A competitive version of ABPP identifies the target(s) and assesses the selectivity of an enzyme inhibitor in biological systems by gauging how well the inhibitor slows the enzyme s reaction with an ABP. For example, fluorophosphonate ABP 3 was used to profile the selectivity of fatty acid amide hydrolase (FAAH) inhibitors within the serine hydrolase superfamily [27] (FAAH hydrolyzes endocannabinoids such as anandamide). Serine hydrolases that exhibited reduced labeling by the probe in the presence of inhibitor were scored as targets of the inhibitor. Urea FAAH inhibitors exemplified by PF-3845 (5) that covalently modify the active-site serine nucleophile of FAAH were found to be exquisitely selective for FAAH in brain and liver... [Pg.351]

Several approaches have been undertaken to construct redox active polymermodified electrodes containing such rhodium complexes as mediators. Beley [70] and Cosnier [71] used the electropolymerization of pyrrole-linked rhodium complexes for their fixation at the electrode surface. An effective system for the formation of 1,4-NADH from NAD+ applied a poly-Rh(terpy-py)2 + (terpy = terpyridine py = pyrrole) modified reticulated vitreous carbon electrode [70]. In the presence of liver alcohol dehydrogenase as production enzyme, cyclohexanone was transformed to cyclohexanol with a turnover number of 113 in 31 h. However, the current efficiency was rather small. The films which are obtained by electropolymerization of the pyrrole-linked rhodium complexes do not swell. Therefore, the reaction between the substrate, for example NAD+, and the reduced redox catalyst mostly takes place at the film/solution interface. To obtain a water-swellable film, which allows the easy penetration of the substrate into the film and thus renders the reaction layer larger, we used a different approach. Water-soluble copolymers of substituted vinylbipyridine rhodium complexes with N-vinylpyrrolidone, like 11 and 12, were synthesized chemically and then fixed to the surface of a graphite electrode by /-irradiation. The polymer films obtained swell very well in aqueous... [Pg.112]

The mechanism of toxification of isoniazid was investigated in rats pretreated with inducers or inhibitors of microsomal enzymes or an inhibitor of acylamidases. In animals pretreated with the acylamidase inhibitor bis(4-nitrophenyl) phosphate, isoniazid and acetylisoniazid produced less liver necrosis than in control animals. The treatment had no effect on the necrosis due to acetylhydrazine [173], In animals pretreated with inducers of microsomal cytochrome P450 such as phenobarbital, acetylisoniazid, and acetylhydrazine caused markedly increased necrosis, while pretreatment with cytochrome P450 inhibitors decreased necrosis. In contrast, the toxicity of isoniazid and hydrazine was not modified by phenobarbital pretreatment. From these observations, Trimbell et al. [173] concluded that the hydrolysis of acetylisoniazid is a prerequisite for hepatotoxicity, and that microsomal enzymes transform acetylhydrazine, the product of hydrolysis, to a toxic species. [Pg.167]

The retention of 1,2-dibromoethane in tissues and body fluids can be altered by concurrent exposure to modifiers of enzyme activity, such as disulfiram (Plotnick et al. 1979). The concentration of radiolabeled 1,2-dibromoethane in the liver, kidneys, spleen, testes, and brain increased significantly in rats fed disulfiram in the diet for 12 days before an oral dose of 15 mg C-1,2- dibromoethane/kg compared with rats not fed disulfiram. Disulfiram, an inhibitor of P-450 metabolism (via action on acetaldehyde dehydrogenase), was found to increase the uptake of C into liver nuclei. These observations correlate well with the results of chronic studies (Wong et al. 1982) that demonstrated enhanced tumorigenic effects in the liver and testes following combined 1,2-dibromoethane and disulfiram exposure. [Pg.48]

To do this work, liver cells have an abundance of enzymes that inactivate these chemicals either by cutting off (cleaving) pieces of the molecules or modifying the... [Pg.26]

This is essentially a tnbe rnnning from month to anns. It is, conventionally, considered to inclnde the associated glands liver, pancreas and gall bladder. It provides the enzymes required for digestion, the chambers in which this occnrs and the mechanism for the absorption of the prod-nets of digestion. A major fnnetion of the liver is to chemically modify and store many of the prodnets of digestion and detoxify or inactivate those that may be injnrions to health. [Pg.12]


See other pages where Liver modified enzymes is mentioned: [Pg.100]    [Pg.266]    [Pg.69]    [Pg.413]    [Pg.707]    [Pg.427]    [Pg.315]    [Pg.162]    [Pg.143]    [Pg.234]    [Pg.310]    [Pg.533]    [Pg.258]    [Pg.536]    [Pg.10]    [Pg.266]    [Pg.719]    [Pg.203]    [Pg.220]    [Pg.53]    [Pg.96]    [Pg.577]    [Pg.830]    [Pg.103]    [Pg.365]    [Pg.704]    [Pg.911]    [Pg.1376]    [Pg.274]    [Pg.370]    [Pg.390]    [Pg.419]    [Pg.7]    [Pg.192]    [Pg.306]   
See also in sourсe #XX -- [ Pg.141 , Pg.142 , Pg.143 , Pg.144 , Pg.145 , Pg.146 , Pg.147 ]




SEARCH



Enzyme liver

Enzyme modifiers

Modified Enzymes

© 2024 chempedia.info